Noninvasive Detection of Bladder Cancer in an Orthotopic Murine Model With Green Fluorescence Protein Cytology
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (3) , 975-978
- https://doi.org/10.1097/01.ju.0000073209.65128.c1
Abstract
Orthotopic models of bladder cancer mimic the normal microenvironment and provide an opportunity to study new therapies for superficial bladder cancer. The use of green fluorescent protein (GFP) transduced cells provides a sensitive way of monitoring this disease. We investigated whether examining voided urine for GFP expressing cells would indicate the presence of GFP producing tumors in an orthotopic bladder tumor model in nude mice. The human bladder cancer cell lines KU-7, UM-UC-3 and UM-UC-14 were used. GFP transductants were generated after transfection with pEGFP-N3, followed by G418 selection. After the cells were inoculated in an orthotopic model of superficial bladder cancer voided urine was collected on slides weekly for 3 weeks and observed for GFP expressing cells by fluorescence microscopy. Bladder tumor imaging for GFP was performed in surgically exposed bladders to determine the tumor incidence. KU-7 GFP cells produced tumors in all 16 mice on whole bladder GFP imaging. UM-UC-3 and UM-UC-14 GFP cells produced tumors in 8 of 12 (67%) and 18 of 25 (72%) mice, respectively. The rate of GFP positive cells in spontaneously voided urine varied by cell line and increased with time but it was generally less than the rate of detection by whole bladder GFP imaging. All mice with GFP expressing cells in the urine had GFP expressing bladder tumors. Examining urine for GFP expressing cells is less sensitive than imaging surgically exposed bladders but it is 100% specific.Keywords
This publication has 13 references indexed in Scilit:
- Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expressionCancer Gene Therapy, 2002
- Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector InstillationJournal of Clinical Oncology, 2002
- USE OF GREEN FLUORESCENT PROTEIN TO MEASURE TUMOR GROWTH IN AN IMPLANTED BLADDER TUMOR MODELJournal of Urology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapiesCancer Gene Therapy, 2000
- Gene therapy for bladder cancer.World Journal of Urology, 2000
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- Isolation and Characterization of Metastatic Variants from Human Transitional Cell Carcinoma Passaged by Orthotopic Implantation in Athymic Nude MiceJournal of Urology, 1995
- The Monoclonal Antibody BQ16 Identifies the α6β4 Integrin on Bladder CancerHybridoma, 1993
- Influence of Organ Environment on Extracellular Matrix Degradative Activity and Metastasis of Human Colon Carcinoma CellsJNCI Journal of the National Cancer Institute, 1990